School News

Stern Faces of Change: Xiaobing Qian, TRIUM Global Executive MBA ‘24

A joint offering by NYU Stern, the London School of Economics (LSE), and HEC Paris, the TRIUM Global Executive MBA program is the only global EMBA that integrates sociopolitics with business in an immersive learning environment of Africa, the Americas, Asia, Europe and the Middle East.

TRIUM has continually innovated its curriculum to align with the evolving demands of the global business landscape. Recently, these updates have emphasized enhanced geopolitical awareness and strengthening leadership capabilities. Module locations have expanded to include major global cities such as Seoul, Nairobi, and Dubai, offering students a truly international perspective. Each location is selected to provide a regional context to the subjects taught, and to provide insight into regions that are becoming increasingly influential.

And the addition of new courses on cutting-edge trends, including environmental, social, and governance (ESG) topics, artificial intelligence (AI), and other contemporary issues, to equip leaders with the skills and insights necessary to proactively navigate the complexities of the modern world.

Learn more about TRIUM from recent alumna Xiaobing Qian TRIUM Global Executive MBA ’24:

A violet graphic with a headshot of Xiaobing Qian that says: "Stern Faces of Change, Xiaobing Qian TRIUM global executive MBA ’24."

Current Organization

Chief Development Officer at Degron Therapeutics

Why did you choose TRIUM?

I applied to TRIUM because I believed it would provide an invaluable educational experience to enhance my impact as a global business leader. 

COVID accelerated my “why now.” COVID changed all our lives, and for me, brought a profound realization of interconnectedness of people and businesses into a sharp focus.  At the start of the pandemic, I was working at a biotech company in Cambridge, and we have clinical trials going on in Germany, Canada, Australia, and many parts of the US.  It raised the questions: how do we manage patient safety in such an unprecedented health care crisis? How do we continue cross-border collaborations when the rules and regulations change and become more diverse across different countries and regions around the world? How to anticipate and manage business risks in the future? Can we apply the lessons, new technologies, and newfound connections to benefit?

How did TRIUM expand your global experience?

My favorite part of the program was its very unique and deliberate selection of a diverse student body. Our cohort consisted of more than 40 people from over 30 countries, in different industries, stages of their careers, and with varied expertise in finance, tech, pharmaceutical sciences, government, and more. My first study group was comprised of an African government official and business leaders, European executives, Middle East regulatory policy gurus, and a Pakistani general turned entrepreneur. In this miniature “united nations,” we were able to find common ground, collaborate and be successful together.

How are you planning to apply your learnings to your career?

Many of the lessons I learned at TRIUM have an immediate impact on how I lead, manage, and grow Degron Therapeutics. I also found immediate changes in:

  • Leadership styles in different cultures;
  • Application of AI in business (we started to use ChatGPT in the classroom in Module 2);
  • Accounting and finance, particularly how to effectively manage cash flow;
  • Multi-dimensional negotiation and styles of negotiation that lead to win-win;
  • Doing business in Asia, especially how to lean on relationships while adhering to rules and standards.

Stern’s brand call to action is all around embracing change. How have you seen this program changing your future?

Medical innovations are happening at warp speed across the globe. My short-term professional objective is to help entrepreneurs rapidly develop and advance their innovative therapeutics, and graduating from TRIUM has helped hone the skills I need to accomplish this.